Application note: Flow cytometry platform
Compendium of iQue® advanced flow cytometry platform application posters: Antibody discovery and immuno-oncology.
List view / Grid view
Compendium of iQue® advanced flow cytometry platform application posters: Antibody discovery and immuno-oncology.
This ebook explores the role of binding kinetics in drug discovery, current methods for kinetic parameter analysis, novel approaches and applications.
Using screening techniques, researchers have identified the compound called AN15368 which works as an antiparasitic against Chagas disease.
Trust in your results — Experience the benefits of iQue® advanced flow cytometry.
7 September 2022 | By Sartorius
Watch this webinar to hear from Dr Yuansheng Yang as he introduces a CHO cell-based technology allowing simultaneous display and secretion of antibodies for accelerating the process of antibody development.
Application note: Quantifying T Cell response in 3D tumour spheroids using advanced flow cytometry workflows.
This publications review overviews advanced flow cytometry applications in infectious disease and immuno-oncology.
This guide highlights the four major stages of TPD, the challenges at each step and questions you should ask yourself.
This whitepaper overviews how high throughput, multi-parametric analysis accelerates antibody discovery workflows.
Researchers from the US have identified several new small molecules that can induce mitophagy in leukaemia cells.
Here Bio-Rad presents the generation of specific anti-CAR T-cell antibodies to show how CAR T-cell analysis benefits from our modular antibody assembly technology using SpyTag-SpyCatcher protein ligation.
9 May 2022 | By PerkinElmer and C4
Looking for a way to address the undruggable proteins in the human body? Watch this free on-demand webinar where industry experts discuss strategies to accelerate TPD drug discovery efforts using high-throughput cell-based assays.
6 May 2022 | By Eurofins Discovery
Watch our free on-demand webinar to learn how to accelerate screening and Structure Activity Relationship (SAR) analysis in the targeted protein degradation (TPD) drug discovery field.
14 April 2022 | By Eurofins Discovery Services
Watch this free on-demand webinar to understand how to rapidly identify selective, specific, potent and tractable hit series with appropriate ADME characteristics to speed up hit-to-lead.
A review of current challenges and goals in cardiac drug discovery and how innovations on human iPSC technology are helping to overcome them.